In this study, we modulated the expression of IL-7Rα and used inhibitors to show that IL-7 directly increases the migration and invasion of prostate cancer cells and assessed the potential of IL-7 and IL-7Rα as targets for anticancer drugs. Here, IL7R is linked to prostate carcinoma.